Published in Dtsch Med Wochenschr on September 09, 1988
Testing the integrity of a psychotherapy protocol: assessment of adherence and competence. J Consult Clin Psychol (1993) 4.73
A component analysis of cognitive-behavioral treatment for depression. J Consult Clin Psychol (1996) 4.06
Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group. Gastroenterology (1993) 2.83
Structured reporting of medical findings: evaluation of a system in gastroenterology. Methods Inf Med (1992) 2.30
Hepatitis C virus infection is a risk factor for liver failure from veno-occlusive disease after bone marrow transplantation. Blood (1994) 2.16
A prognostic computer model to individually predict post-procedural complications in interventional cardiology: the INTERVENT Project. Eur Heart J (1999) 1.98
Acute hepatitis A in haemophiliacs. Lancet (1992) 1.96
HLA DR4 antibodies cause positive HTLV-III antibody ELISA results. Lancet (1985) 1.69
A prognostic computer model to predict individual outcome in interventional cardiology. The INTERVENT Project. Eur Heart J (1997) 1.61
Systemic scleroderma. Multicenter trial of 1 year of treatment with recombinant interferon gamma. Arch Dermatol (1997) 1.49
DNA probes for identification of clinically important Bacteroides species. J Clin Microbiol (1986) 1.47
Quantitative liver function tests as surrogate markers for end-points in controlled clinical trials: a retrospective feasibility study. Hepatology (1997) 1.43
Classical homeopathic treatment of chronic headaches. Cephalalgia (1997) 1.43
The procedure of new drug application and the philosophy of critical rationalism or the limits of quality assurance with good clinical practice. Control Clin Trials (1999) 1.41
High-volume nonionic dimeric contrast medium: first experiences during complex coronary interventions. Cathet Cardiovasc Diagn (1997) 1.39
The first case of HCV seroconversion after 3 years of HCV NAT screening in Baden-Württemberg. Transfusion (2000) 1.38
An epidemiologic survey of human alveolar echinococcosis in southwestern Germany. Römerstein Study Group. Am J Trop Med Hyg (1999) 1.36
Hemalog-D and manual differential leukocyte counts. A laboratory comparison of results obtained with blood of hospitalized patients. Am J Clin Pathol (1975) 1.30
Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA. Lancet (2000) 1.26
A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis. Gut (1999) 1.26
Response of adult patients with osteomalacia to treatment with crystalline 1alpha-hydroxy vitamin D3. N Engl J Med (1974) 1.24
Recommendations of the German Association for Medical Informatics, Biometry and Epidemiology for education and training in medical informatics. Methods Inf Med (1992) 1.16
Mini-pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus, and HIV: preliminary results. Transfusion (1998) 1.13
Changes in QRS voltage in cardiac tamponade and pericardial effusion: reversibility after pericardiocentesis and after anti-inflammatory drug treatment. J Am Coll Cardiol (2001) 1.11
Hepatitis B immunisation before entry into medical school. Lancet (1994) 1.09
Kava extracts: safety and risks including rare hepatotoxicity. Phytomedicine (2003) 1.07
[HIV retrospective study of the German Red Cross blood donation service in Germany]. Infusionsther Transfusionsmed (1994) 1.07
A new method for the titration of lymphocytic choriomeningitis viruses. Arch Gesamte Virusforsch (1967) 1.04
[Efficiency of homeopathic preparation combinations in sinusitis. Results of a randomized double blind study with general practitioners]. Arzneimittelforschung (1989) 0.99
Identification of platelet proteins separated by two-dimensional gel electrophoresis and analyzed by matrix assisted laser desorption/ionization-time of flight-mass spectrometry and detection of tyrosine-phosphorylated proteins. Electrophoresis (2000) 0.97
Tissue donation and virus safety: more nucleic acid amplification testing is needed. Transpl Infect Dis (2010) 0.97
Results of a multicenter placebo-controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon-gamma. Rheumatol Int (1988) 0.97
Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study. Exp Clin Endocrinol Diabetes (2008) 0.97
Results of a phase-II clinical trial on treatment of rheumatoid arthritis with recombinant interferon-gamma. Rheumatol Int (1987) 0.95
Epidemiology and immunogenetic background of islet cell antibody--positive nondiabetic schoolchildren. Ulm-Frankfurt population study. Diabetes (1991) 0.95
Seroprevalence and determinants of diphtheria, tetanus and poliomyelitis antibodies among adults in Berlin, Germany. Vaccine (1999) 0.94
[Pollinosis therapy with Galphimia glauca]. Fortschr Med (1983) 0.94
Hospital-wide outbreak of Burkholderia contaminans caused by prefabricated moist washcloths. J Hosp Infect (2011) 0.94
Unsatisfactory specificities and sensitivities of six enzyme immunoassays for antibodies to hepatitis B core antigen. J Clin Microbiol (1989) 0.94
Double-blind trial comparing the effectiveness of the homeopathic preparation Galphimia potentiation D6, Galphimia dilution 10(-6) and placebo on pollinosis. Arzneimittelforschung (1985) 0.93
Prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage: prospective, randomized comparison of propranolol and sclerotherapy. Hepatology (1987) 0.93
Risk factors for infections of the oropharynx and the respiratory tract in patients with acute leukemia. J Infect Dis (1981) 0.92
Pathogenesis of Rh immunization in primigravidas. Fetomaternal versus maternofetal bleeding. Obstet Gynecol (1977) 0.91
Persuasion criteria in research and practice: Gathering more meaningful psychotherapy data. Behav Anal (1993) 0.91
Once-daily versus thrice-daily dosing of netilmicin in combination with beta-lactam antibiotics as empirical therapy for febrile neutropenic patients. J Antimicrob Chemother (1993) 0.90
Results of applying ADCON-L gel after lumbar discectomy: the German ADCON-L study. J Neurosurg (2001) 0.90
Supportive pentoxifylline in falciparum malaria: no effect on tumor necrosis factor alpha levels or clinical outcome: a prospective, randomized, placebo-controlled study. Am J Trop Med Hyg (1997) 0.89
Purification of threonine deaminase from Escherichia coli. FEBS Lett (1973) 0.89
[Reversible germ cell toxicity following aggressive chemotherapy in patients with testicular tumors: results of a prospective study]. Klin Wochenschr (1989) 0.88
Survival and prognosis: investigation of Crataegus extract WS 1442 in congestive heart failure (SPICE)--rationale, study design and study protocol. Eur J Heart Fail (2000) 0.87
Ciprofloxacin and norfloxacin for selective decontamination in patients with severe granulocytopenia. Infection (1988) 0.86
X-ray densitometry for the measurement of regional myocardial perfusion. Basic Res Cardiol (2000) 0.85
Colostrinin (a naturally occurring, proline-rich, polypeptide mixture) in the treatment of Alzheimer's disease. J Alzheimers Dis (2004) 0.84
Paying for blood donations--still a risk? Vox Sang (2003) 0.84
[Ulrich and Ulrich oculo-oscillodynamography: results in patients with healthy eyes]. Klin Monbl Augenheilkd (1988) 0.83
Mandatory hepatitis B virus testing for doctors. Lancet (1998) 0.83
[Blood clotting factor XIII substitution in acute leukaemia: result of a randomized and controlled study]. Dtsch Med Wochenschr (1982) 0.83
[Stability of blood coagulation factors in deep frozen fresh plasma by storage at -20 degrees C and -40 degrees C]. Infusionsther Klin Ernahr (1984) 0.83
Low cytokine contamination in buffy coat-derived platelet concentrates without filtration. Transfusion (1996) 0.83
Prevention of infection in acute leukemia: a prospective randomized study on the efficacy of two different drug regimens for antimicrobial prophylaxis. Infection (1987) 0.82
Hepatitis C virus stability: the issue! Vox Sang (1999) 0.82
HLA-DR3 and HLA-DR5 confer risk for autoantibody positivity against the thyroperoxidase (mic-TPO) antigen in healthy blood donors. Clin Investig (1993) 0.82
Normal laboratory values for differential white cell counts established by manual and automated cytochemical methods (Hemalog D-TM). J Clin Pathol (1974) 0.82
Prevalence of HCV-RNA-positive blood donors and correlation to ELISA and RIBA status. Ann Hematol (1993) 0.82
Isotype-specific immune response to a single hepatitis C virus core epitope defined by a human monoclonal antibody: diagnostic value and correlation to PCR. Ann Hematol (1994) 0.81
Comparison of myocardial perfusion reserve before and after coronary balloon predilatation and after stent implantation in patients with postangioplasty restenosis. Circulation (1996) 0.81
Contrast echocardiography for assessment of myocardial perfusion. Herz (1997) 0.81
Effects of stress and exercise on plasma corticosterone, plasma cholesterol, and aortic cholesterol levels in rats. Psychosom Med (1983) 0.80
Self-reported excess body weight in short- and long-sleeping college students. Psychol Rep (1983) 0.80
[The metabolism of organ cultures of cornea in TC 199 with added dextran 500 or hydroxyethyl starch 450]. Klin Monbl Augenheilkd (1990) 0.80
HLA-DRB3 gene alleles in Caucasian patients with Graves' disease. Clin Investig (1992) 0.80
Autologous blood donor screening indicated a lower prevalence of viral hepatitis in East vs West Germany: epidemiological benefit from established health resources. J Viral Hepat (2009) 0.80
Isolation and epitope characterization of human monoclonal antibodies to hepatitis C virus core antigen. Hybridoma (1994) 0.80
Quality assurance by specification and achievement of goals in palliative cancer treatment. Cancer Treat Rev (1996) 0.80
Human monoclonal antibodies for the immunological characterization of a highly conserved protein domain of the hepatitis C virus glycoprotein E1. Clin Exp Immunol (1995) 0.80
Complement activation during plasma production depends on the apheresis technique. Transfus Med (1998) 0.79
[Comparative study of the cost-/effectiveness relationship of initial therapy with imipenem/cilastatin in nosocomial pneumonia. Group study]. Anasthesiol Intensivmed Notfallmed Schmerzther (1996) 0.79
Immunogenetic markers in patients with Graves' disease. Klin Wochenschr (1991) 0.79
[Comparative study of the cost-effectiveness of initial therapy with imipenem/cilastatin in secondary peritonitis]. Chirurg (1998) 0.79
Tolerability of timolol and betaxolol in patients with chronic open-angle glaucoma. Clin Ther (1987) 0.78
Practical ideas for difficult extractions. Dent Econ (1992) 0.78
Evaluation of the risk of PRRSV transmission via ingestion of muscle from persistently infected pigs. Transbound Emerg Dis (2008) 0.78
Change-to-Open-Label Design. Proposal and discussion of a new design for clinical parallel-group double-masked trials. Arzneimittelforschung (1994) 0.78
Guidelines for reporting non-randomised studies. Forsch Komplementarmed Klass Naturheilkd (2004) 0.78
Camphor-Crataegus berry extract combination dose-dependently reduces tilt induced fall in blood pressure in orthostatic hypotension. Phytomedicine (2002) 0.78
Purification of biosynthetic threonine deaminase from Escherichia coli. Biochim Biophys Acta (1975) 0.78
Experiences in HCV-NAT screening prior to releasing cellular components by the German Red Cross Blood Transfusion Service of Baden-Württemberg. Biologicals (1999) 0.78
[Factors influencing the variability of tear film break-up time]. Klin Monbl Augenheilkd (1983) 0.78
[Normalization of myocardial perfusion reserve after coronary stent implantation in comparison with balloon angioplasty alone]. Z Kardiol (1996) 0.78
Efficacy of oral ofloxacin for single-dose perioperative prophylaxis in general surgery--a controlled randomized clinical study. Langenbecks Arch Surg (2001) 0.77
Anti-HCV envelope prevalence in blood donors from Baden-Württemberg. Ann Hematol (1997) 0.77
[Phenylalanine hydroxylase activity in heterozygote hereditary carriers of the phenylketonuria gene]. Acta Biol Med Ger (1977) 0.77